Myasthenia Gravis: A Review of Available Treatment Approaches

Patients with autoimmune myasthenia gravis (MG) should be further classified before initiating therapy, as treatment response varies for ocular versus generalised, early onset versus late onset, and acetylcholine receptor antibody positive versus MuSK antibody positive disease. Most patients need im...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilhus, Nils Erik, Owe, Jone F., Hoff, Jana Midelfart, Romi, Fredrik, Skeie, Geir Olve, Aarli, Johan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189457/
https://www.ncbi.nlm.nih.gov/pubmed/22007295
http://dx.doi.org/10.4061/2011/847393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189457/
https://www.ncbi.nlm.nih.gov/pubmed/22007295
http://dx.doi.org/10.4061/2011/847393

Ejemplares similares